期刊论文详细信息
International Journal of Pediatric Endocrinology
Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor
Stephen M Rosenthal1  Stephen E Gitelman1  Sayali A Ranadive3  Melissa A Cadnapaphornchai2  Clement C Cheung1 
[1] Department of Pediatrics, Division of Endocrinology, University of California, San Francisco, San Francisco, CA 94143;Department of Pediatrics, Division of Nephrology, University of Colorado Denver, Aurora, CO 80045;Pediatric Endocrinology, Palo Alto Medical Foundation, Fremont, CA 94538
关键词: Water Loading;    V2R;    NSIAD;    Aquaporin-2;   
Others  :  813585
DOI  :  10.1186/1687-9856-2012-3
 received in 2011-12-20, accepted in 2012-02-10,  发布年份 2012
PDF
【 摘 要 】

Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) is a novel disease caused by a gain-of-function mutation in the V2 vasopressin receptor (V2R), which results in water overload and hyponatremia. We report the effect of water loading in a 3-year old boy with NSIAD, diagnosed in infancy, to assess urine aquaporin-2 (AQP2) excretion as a marker for V2R activation, and to evaluate the progression of the disease since diagnosis. The patient is one of the first known NSIAD patients and the only patient with a R137L mutation. Patient underwent a standard water loading test in which serum and urine sodium and osmolality, serum AVP, and urine AQP2 excretion were measured. The patient was also evaluated for ad lib fluid intake before and after the test. This patient demonstrated persistent inability to excrete free water. Only 39% of the water load (20 ml/kg) was excreted during a 4-hour period (normal ≥ 80-90%). Concurrently, the patient developed hyponatremia and serum hypoosmolality. Serum AVP levels were detectable at baseline and decreased one hour after water loading; however, urine AQP2 levels were elevated and did not suppress normally during the water load. The patient remained eunatremic but relatively hypodipsic during ad lib intake. In conclusion, this is the first demonstration in a patient with NSIAD caused by a R137L mutation in the V2R that urine AQP2 excretion is inappropriately elevated and does not suppress normally with water loading. In addition, this is the first longitudinal report of a pediatric patient with NSIAD diagnosed in infancy who demonstrates the ability to maintain eunatremia during ad lib dietary intake.

【 授权许可】

   
2012 Cheung et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140710005506895.pdf 608KB PDF download
Figure 3. 17KB Image download
Figure 2. 23KB Image download
Figure 1. 24KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】
  • [1]Schrier RW, Cadnapaphornchai MA: Renal aquaporin water channels: from molecules to human disease. Prog Biophys Mol Biol 2003, 81:117-131.
  • [2]Elliot S, Goldsmith P, Knepper M, Haughey M, Olson B: Urinary excretion of aquaporin-2 in humans: a potential marker of collecting duct responsiveness to vasopressin. J Am Soc Nephrol 1996, 7:403-409.
  • [3]Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, et al.: Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 1995, 332:1540-1545.
  • [4]Saito T, Ishikawa SE, Ando F, Okada N, Nakamura T, et al.: Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin. J Clin Endocrinol Metab 1998, 83:4034-4040.
  • [5]Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, et al.: Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 2005, 352:1884-1890.
  • [6]Gether U, Kobilka BK: G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 1998, 273:17979-17982.
  • [7]Bes DF, Mendilaharzu H, Fenwick RG, Arrizurieta E: Hyponatremia resulting from arginine vasopressin receptor 2 gene mutation. Pediatr Nephrol 2007, 22:463-466.
  • [8]Cho YH, Gitelman S, Rosenthal S, Ambler G: Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis. Int J Pediatr Endocrinol 2009, 2009:431527. BioMed Central Full Text
  • [9]Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, et al.: Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 2007, 18:606-612.
  • [10]Gupta S, Cheetham TD, Lambert HJ, Roberts C, Bourn D, et al.: Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis. Eur J Endocrinol 2009, 161:503-508.
  • [11]Marcialis MA, Faa V, Fanos V, Puddu M, Pintus MC, et al.: Neonatal onset of nephrogenic syndrome of inappropriate antidiuresis. Pediatr Nephrol 2008, 23:2267-2271.
  • [12]Ranchin B, Boury-Jamot M, Blanchard G, Dubourg L, Hadj-Aissa A, et al.: Familial nephrogenic syndrome of inappropriate antidiuresis: dissociation between aquaporin-2 and vasopressin excretion. J Clin Endocrinol Metab 2010, 95:E37-43.
  • [13]Goldman MB, Luchins DJ, Robertson GL: Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988, 318:397-403.
  • [14]Pedersen RS, Bentzen H, Bech JN, Nyvad O, Pedersen EB: Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney Int 2003, 63:1417-1425.
  • [15]Umenishi F, Summer SN, Cadnapaphornchai M, Schrier RW: Comparison of three methods to quantify urinary aquaporin-2 protein. Kidney Int 2002, 62:2288-2293.
  • [16]Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW: Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA 1993, 90:11663-11667.
  • [17]Huang EA, Feldman BJ, Schwartz ID, Geller DH, Rosenthal SM, et al.: Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr 2006, 148:128-131.
  • [18]Holliday MA, Segar WE: The maintenance need for water in parenteral fluid therapy. Pediatrics 1957, 19:823-832.
  • [19]Kluge M, Riedl S, Erhart-Hofmann B, Hartmann J, Waldhauser F: Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children. Clin Chem 1999, 45:98-103.
  文献评价指标  
  下载次数:13次 浏览次数:10次